|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
18
|
|
pubmed:dateCreated |
2008-6-20
|
|
pubmed:abstractText |
Corticosteroids are a critical component of therapy for acute lymphoblastic leukemia (ALL) but are associated with late effects, such as osteoporosis. Risk factors remain poorly defined. Because CRHR1 polymorphisms have been associated with other corticosteroid effects, our goal was to define whether CRHR1 polymorphisms predict which patients with ALL are likely to develop bone mineral deficits.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3031-7
|
|
pubmed:meshHeading |
pubmed-meshheading:18565889-Adolescent,
pubmed-meshheading:18565889-Adrenal Cortex Hormones,
pubmed-meshheading:18565889-Adult,
pubmed-meshheading:18565889-Bone Density,
pubmed-meshheading:18565889-Female,
pubmed-meshheading:18565889-Haplotypes,
pubmed-meshheading:18565889-Humans,
pubmed-meshheading:18565889-Male,
pubmed-meshheading:18565889-Polymorphism, Single Nucleotide,
pubmed-meshheading:18565889-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:18565889-Receptors, Corticotropin-Releasing Hormone,
pubmed-meshheading:18565889-Survivors
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
CRHR1 polymorphisms predict bone density in survivors of acute lymphoblastic leukemia.
|
|
pubmed:affiliation |
Department of Radiology, Colleges of Pharmacy and Medicine, University of Tennessee, Memphis, TN, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
